Investment Analysts’ Updated EPS Estimates for September 9th (BIOA, BNED, BRZE, CHYM, FELE, IRD, NBIS, ORCL, PII, SAIL)

Investment Analysts’ updated eps estimates for Wednesday, September 9th:

BioAge Labs (NASDAQ:BIOA) had its buy rating reiterated by analysts at Roth Capital. The firm currently has a $25.00 target price on the stock.

Barnes & Noble Education (NYSE:BNED) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $16.00 target price on the stock.

Braze (NASDAQ:BRZE) had its buy rating reaffirmed by analysts at DA Davidson. DA Davidson currently has a $40.00 price target on the stock.

Chime Financial (NASDAQ:CHYM) had its target price increased by Scotiabank from $40.00 to $42.00. Scotiabank currently has a sector outperform rating on the stock.

Franklin Electric (NASDAQ:FELE) had its neutral rating reiterated by analysts at DA Davidson. They currently have a $105.00 price target on the stock.

Opus Genetics (NASDAQ:IRD) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $8.00 price target on the stock.

Opus Genetics (NASDAQ:IRD) had its target price boosted by Oppenheimer Holdings, Inc. from $10.00 to $20.00. Oppenheimer Holdings, Inc. currently has an outperform rating on the stock.

Truist Financial Corporation began coverage on shares of Nebius Group (NASDAQ:NBIS). They issued a buy rating and a $355.00 target price on the stock.

Oracle (NYSE:ORCL) had its target price lowered by Scotiabank from $241.00 to $215.00. They currently have a sector outperform rating on the stock.

Polaris (NYSE:PII) had its price target cut by Citigroup Inc. from $73.00 to $67.00. They currently have a neutral rating on the stock.

SailPoint (NASDAQ:SAIL) had its buy rating reaffirmed by analysts at BTIG Research. BTIG Research currently has a $21.00 target price on the stock.

Signet Jewelers (NYSE:SIG) had its price target increased by Wells Fargo & Company from $90.00 to $100.00. They currently have an equal weight rating on the stock.

ServiceTitan (NASDAQ:TTAN) had its target price reduced by Citigroup Inc. from $83.00 to $76.00. The firm currently has a neutral rating on the stock.

WaFd (NASDAQ:WAFD) had its price target lowered by DA Davidson from $40.00 to $37.00. DA Davidson currently has a neutral rating on the stock.

Receive News & Ratings for BioAge Labs Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioAge Labs Inc and related companies with MarketBeat.com's FREE daily email newsletter.